Prevention of influenza by use of intradermal vaccination
Authors:
J. Kynčl
Authors place of work:
Státní zdravotní ústav Praha, Centrum odborných činností v OPVZ, Odbor epidemiologie infekčních nemocí a Univerzita Karlova v Praze, 3. lékařská fakulta, Ústav epidemiologie
Published in the journal:
Čas. Lék. čes. 2009; 148: 191-193
Category:
Topic
Summary
Intradermal vaccination against influenza represents a new method of protection against the heavy incidence disease. For its very good immunity response, intradermal injections are frequently used for many types of vaccines. Results of clinical studies are presented and the system of intradermal microinjections for vaccine administration is introduced. Sensitive vaccination can increase the prevalence of vaccinated persons and thus decrease morbidity and mortality of influenza.
Key words:
influenza, influenza vaccine, intradermal, microinjection, immune response.
Zdroje
1. Kyncl J, Prochazka B, Goddard NL, et al. A study of excess mortality during influenza epidemics in the Czech Republic, 1982-2000. Eur J Epidemiol 2005; 20: 365–371.
2. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Commun Dis Public Health 2000; 3: 32–38.
3. Beran J, Havlík J. Chřipka. Klinický obraz, prevence, léčba. 2. rozšířené vydání. Praha: Maxdorf 2005; 1–175.
4. Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008; 7: 1201–1214.
5. Leroux-Roels I, Vets E, Freese R, et al. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Vaccine 2008; 26: 6614–6619.
6. Beran J, Ambrozaitis A, Laiskonis A, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009; 7: 13.
7. Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008; 198: 650–658.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Contemporary clinical medicine – assurances and uncertainties
- Minimally invasive thyroidectomy
- What is spirituality and how it helps
- Quality of life of Crohn’s disease patients